Pharma Journalist - Page 881 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Callery Corporation appoints Dr. Harry Rathore as CEO

Sandoz Canada launches Sandoz Olmesartan for the treatment of high blood pressure

Propanc Biopharma Provides Update on IMP Manufacture of PRP for First-In-Human Studies

AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services

Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears

Oramed Receives Israel Regulatory Approval to Conduct Human Study for New Oral Leptin Capsule

Stealth BioTherapeutics Initiates Phase 1/2 Trial of SBT-20 in Patients With Early Stage Huntington’s Disease

Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland

Concert Pharmaceuticals Initiates CTP-543 Phase 2 Trial in Alopecia Areata